Patents by Inventor Ian Peter Flawn ORPANA

Ian Peter Flawn ORPANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975165
    Abstract: A drug delivery system that includes an elongated inert support and at least two reservoirs containing a pharmaceutically active ingredient. The inert support has a number of wall segments that define at least two compartments arranged for accommodating the at least two reservoirs. The inert support is made of a material which prevents migration or diffusion of the active ingredient from one reservoir into the other or into the support. Since the drug delivery system is divided into compartments, one for each reservoir containing an active ingredient, the release rates of each active ingredient can be independently controlled or adjusted. This is due to the fact that there is no interaction between the active ingredients, and accordingly the active ingredients will not influence each other physically or chemically.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: May 7, 2024
    Assignee: QPHARMA AB
    Inventors: John Ingvar Feldtblad Kendrup, Steen Alex Stavnshøj, Ian Peter Flawn Orpana
  • Publication number: 20160136402
    Abstract: A drug delivery system that includes an elongated inert support and at least two reservoirs containing a pharmaceutically active ingredient. The inert support has a number of wall segments that define at least two compartments arranged for accommodating the at least two reservoirs. The inert support is made of a material which prevents migration or diffusion of the active ingredient from one reservoir into the other or into the support. Since the drug delivery system is divided into compartments, one for each reservoir containing an active ingredient, the release rates of each active ingredient can be independently controlled or adjusted. This is due to the fact that there is no interaction between the active ingredients, and accordingly the active ingredients will not influence each other physically or chemically.
    Type: Application
    Filed: September 11, 2014
    Publication date: May 19, 2016
    Inventors: John Ingvar Feldtblad KENDRUP, Steen Alex STAVNSHØJ, Ian Peter Flawn ORPANA